These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9587185)

  • 41. Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity.
    McClain MS; Czajkowsky DM; Torres VJ; Szabo G; Shao Z; Cover TL
    Infect Immun; 2006 Nov; 74(11):6188-95. PubMed ID: 16954403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brefeldin A enhances Helicobacter pylori vacuolating cytotoxin-induced vacuolation of epithelial cells.
    Argent RH; McGarr C; Atherton JC
    FEMS Microbiol Lett; 2004 Aug; 237(1):163-70. PubMed ID: 15268952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The VacA toxin of Helicobacter pylori identifies a new intermediate filament-interacting protein.
    de Bernard M; Moschioni M; Napolitani G; Rappuoli R; Montecucco C
    EMBO J; 2000 Jan; 19(1):48-56. PubMed ID: 10619843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.
    McClain MS; Cao P; Iwamoto H; Vinion-Dubiel AD; Szabo G; Shao Z; Cover TL
    J Bacteriol; 2001 Nov; 183(22):6499-508. PubMed ID: 11673417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detoxification of the Helicobacter pylori cytotoxin.
    Manetti R; Massari P; Marchetti M; Magagnoli C; Nuti S; Lupetti P; Ghiara P; Rappuoli R; Telford JL
    Infect Immun; 1997 Nov; 65(11):4615-9. PubMed ID: 9353041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A.
    Cruz-Migoni A; Hautbergue GM; Artymiuk PJ; Baker PJ; Bokori-Brown M; Chang CT; Dickman MJ; Essex-Lopresti A; Harding SV; Mahadi NM; Marshall LE; Mobbs GW; Mohamed R; Nathan S; Ngugi SA; Ong C; Ooi WF; Partridge LJ; Phillips HL; Raih MF; Ruzheinikov S; Sarkar-Tyson M; Sedelnikova SE; Smither SJ; Tan P; Titball RW; Wilson SA; Rice DW
    Science; 2011 Nov; 334(6057):821-4. PubMed ID: 22076380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and characterization of the vacuolating toxin from Helicobacter pylori.
    Cover TL; Blaser MJ
    J Biol Chem; 1992 May; 267(15):10570-5. PubMed ID: 1587837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid interaction of the 37-kDa and 58-kDa fragments of the Helicobacter pylori cytotoxin.
    Moll G; Papini E; Colonna R; Burroni D; Telford J; Rappuoli R; Montecucco C
    Eur J Biochem; 1995 Dec; 234(3):947-52. PubMed ID: 8575456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the C-terminal domain of Helicobacter pylori vacuolating toxin and its relationship with extracellular toxin production.
    Wang HJ; Chang PC; Kuo CH; Tzeng CS; Wang WC
    Biochem Biophys Res Commun; 1998 Sep; 250(2):397-402. PubMed ID: 9753641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro cytotoxic effects of vacuolating cytotoxin produced by clinical isolates of Helicobacter pylori.
    Kodama K; Fujioka T; Ito A; Nishizono A; Nasu M
    Kansenshogaku Zasshi; 1998 Oct; 72(10):1027-34. PubMed ID: 9847519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Character and origin of vacuoles induced in mammalian cells by the cytotoxin of Helicobacter pylori.
    Catrenich CE; Chestnut MH
    J Med Microbiol; 1992 Dec; 37(6):389-95. PubMed ID: 1460658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori vacuolating cytotoxin binds to the 140-kDa protein in human gastric cancer cell lines, AZ-521 and AGS.
    Yahiro K; Niidome T; Hatakeyama T; Aoyagi H; Kurazono H; Padilla PI; Wada A; Hirayama T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):629-32. PubMed ID: 9299564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter pylori cytotoxin: a novel ligand for receptor-like protein tyrosine phosphatase beta (review).
    Inui T; Mizuno S; Takai K; Nakagawa M; Uchida M; Fujimiya M; Asakawa A; Inui A
    Int J Mol Med; 2003 Dec; 12(6):917-21. PubMed ID: 14612966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Free-soluble and outer membrane vesicle-associated VacA from Helicobacter pylori: Two forms of release, a different activity.
    Ricci V; Chiozzi V; Necchi V; Oldani A; Romano M; Solcia E; Ventura U
    Biochem Biophys Res Commun; 2005 Nov; 337(1):173-8. PubMed ID: 16182250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimized conditions for the fermentation of Helicobacter pylori and production of vacuolating cytotoxin.
    Marchini A; Massari P; Manetti R; Olivieri R
    FEMS Microbiol Lett; 1994 Nov; 124(1):55-9. PubMed ID: 8001770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vacuolating cytotoxin purified from Helicobacter pylori causes mitochondrial damage in human gastric cells.
    Kimura M; Goto S; Wada A; Yahiro K; Niidome T; Hatakeyama T; Aoyagi H; Hirayama T; Kondo T
    Microb Pathog; 1999 Jan; 26(1):45-52. PubMed ID: 9973580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets.
    Eaton KA; Cover TL; Tummuru MK; Blaser MJ; Krakowka S
    Infect Immun; 1997 Aug; 65(8):3462-4. PubMed ID: 9234813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin.
    Nguyen VQ; Caprioli RM; Cover TL
    Infect Immun; 2001 Jan; 69(1):543-6. PubMed ID: 11119549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deletion of the major proteolytic site of the Helicobacter pylori cytotoxin does not influence toxin activity but favors assembly of the toxin into hexameric structures.
    Burroni D; Lupetti P; Pagliaccia C; Reyrat JM; Dallai R; Rappuoli R; Telford JL
    Infect Immun; 1998 Nov; 66(11):5547-50. PubMed ID: 9784571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular nature of a novel bacterial toxin: the cytolysin of Enterococcus faecalis.
    Haas W; Gilmore MS
    Med Microbiol Immunol; 1999 May; 187(4):183-90. PubMed ID: 10363674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.